Julia Rasmussen

539 total citations
11 papers, 111 citations indexed

About

Julia Rasmussen is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Julia Rasmussen has authored 11 papers receiving a total of 111 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Cancer Research. Recurrent topics in Julia Rasmussen's work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Julia Rasmussen is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Julia Rasmussen collaborates with scholars based in United States and United Kingdom. Julia Rasmussen's co-authors include Andrew J. Armstrong, Daniel J. George, Patrick Healy, J.C. Lund, Michael R. Harrison, Monika Anand, Peter Marleau, J. Macri, Yuan Wu and Susan Halabi and has published in prestigious journals such as Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations and European Urology Oncology.

In The Last Decade

Julia Rasmussen

11 papers receiving 109 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Rasmussen United States 4 65 35 19 18 18 11 111
Thu Nguyen United States 4 39 0.6× 30 0.9× 40 2.1× 15 0.8× 46 2.6× 6 121
Tamás Lörincz Denmark 4 24 0.4× 26 0.7× 17 0.9× 31 1.7× 35 1.9× 5 88
Marie Finn Ireland 11 130 2.0× 64 1.8× 15 0.8× 14 0.8× 43 2.4× 18 292
Jiheon Song Canada 6 35 0.5× 30 0.9× 19 1.0× 6 0.3× 17 0.9× 21 112
Susanna Y. Cheng Canada 5 49 0.8× 12 0.3× 6 0.3× 36 2.0× 14 0.8× 15 92
Rodrigo Hepp Germany 5 59 0.9× 42 1.2× 24 1.3× 13 0.7× 15 0.8× 9 95
Young-Seok Kim South Korea 5 47 0.7× 23 0.7× 12 0.6× 5 0.3× 2 0.1× 12 119
Warren Grant United Kingdom 7 25 0.4× 44 1.3× 5 0.3× 28 1.6× 39 2.2× 11 92
Maiwand Ahmadsei Switzerland 8 72 1.1× 38 1.1× 15 0.8× 40 2.2× 41 2.3× 25 147
Marc Rousseau France 9 127 2.0× 103 2.9× 6 0.3× 21 1.2× 34 1.9× 23 183

Countries citing papers authored by Julia Rasmussen

Since Specialization
Citations

This map shows the geographic impact of Julia Rasmussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Rasmussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Rasmussen more than expected).

Fields of papers citing papers by Julia Rasmussen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Rasmussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Rasmussen. The network helps show where Julia Rasmussen may publish in the future.

Co-authorship network of co-authors of Julia Rasmussen

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Rasmussen. A scholar is included among the top collaborators of Julia Rasmussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Rasmussen. Julia Rasmussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Howard, Lauren E., Bridget F. Koontz, Scott T. Tagawa, et al.. (2024). Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial. European Urology Oncology. 8(2). 287–295. 1 indexed citations
2.
George, Daniel J., Susan Halabi, Mark T. Fleming, et al.. (2024). Overall survival from PANTHER: A multicenter trial of apalutamide, abiraterone acetate plus prednisone in Black and White patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 42(16_suppl). 5072–5072. 2 indexed citations
3.
4.
George, Daniel J., Susan Halabi, Mark T. Fleming, et al.. (2023). A prospective trial of apalutamide and abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.. Journal of Clinical Oncology. 41(16_suppl). 5015–5015. 3 indexed citations
5.
Bitting, Rhonda L., Patrick Healy, Daniel J. George, et al.. (2020). Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. European Urology Oncology. 4(6). 948–954. 23 indexed citations
6.
George, Daniel J., Susan Halabi, Patrick Healy, et al.. (2019). Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 38(3). 79.e15–79.e22. 23 indexed citations
7.
Zhang, Tian, Bridget F. Koontz, Scott T. Tagawa, et al.. (2019). A phase II Salvage Trial of AR Inhibition with ADT and Apalutamide with Radiation therapy followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (STARTAR).. Journal of Clinical Oncology. 37(15_suppl). TPS5097–TPS5097. 1 indexed citations
8.
Armstrong, Andrew J., Rhonda L. Bitting, Patrick Healy, et al.. (2019). Phase II trial enzalutamide and androgen deprivation therapy (ADT) with salvage radiation in men with high-risk PSA recurrent prostate cancer (PC): The STREAM trial.. Journal of Clinical Oncology. 37(7_suppl). 29–29. 2 indexed citations
9.
Ramalingam, Sundhar, Michael Humeniuk, Julia Rasmussen, et al.. (2017). Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate–resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 35(6). 418–424. 20 indexed citations
10.
Mortensen, Erik Lykke, et al.. (2007). Group therapy with OCD. Nordic Psychology. 59(4). 332–346. 3 indexed citations
11.
Lund, J.C., et al.. (2006). Development of a Neutron Scatter Camera for Fission Neutrons. 2006 IEEE Nuclear Science Symposium Conference Record. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thu Nguyen Breakdown of academic impact, for papers by Tamás Lörincz Breakdown of academic impact, for papers by Marie Finn Breakdown of academic impact, for papers by Jiheon Song Breakdown of academic impact, for papers by Susanna Y. Cheng Breakdown of academic impact, for papers by Rodrigo Hepp Breakdown of academic impact, for papers by Young-Seok Kim Breakdown of academic impact, for papers by Warren Grant Breakdown of academic impact, for papers by Maiwand Ahmadsei Breakdown of academic impact, for papers by Marc Rousseau
Rankless by CCL
2026